Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents
Versandkostenfrei!
Versandfertig in über 4 Wochen
27,99 €
inkl. MwSt.
PAYBACK Punkte
14 °P sammeln!
The National Institute of Allergy and Infectious Diseases (NIAID) gives the highest priority to developing countermeasures against bioterrorism agents that are highly infective when dispersed in aerosol form. Developing drugs to prevent or treat illnesses caused by bioterrorism agents requires testing their effectiveness in animals since human clinical trials would be unethical. At the request of NIAID, the National Academies conducted a study to examine how such testing could be improved. Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents provides recomme...